Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating Activities
Net loss, attributable to stockholders	$ (19,989,033)	$ (3,151,209)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion expense		1,306,443
Change in fair value of derivative liability		773,886
Depreciation	10,949	2,601
Discount on convertible notes payable		230,020
Gain on settlement of debt		(1,612,433)
Share-based compensation	115,106
Shares issued for services	16,954,100	1,582,270
Loss on impairment	186,779
Changes in operating assets and liabilities:
Prepaid expenses and deposits	(498,552)	(6,093)
Accounts payable and accrued liabilities	622,655	49,357
Due to related parties		(246,493)
Net Cash Used in Operating Activities	(2,597,996)	(1,071,651)
Investing Activities
Acquisition of equipment	(3,410,558)	(2,094)
Acquisition of water rights	(2,172,750)
Net Cash Used in Investing Activities	(5,583,308)	(2,094)
Financing Activities
Proceeds from issuance of convertible notes payable		1,075,000
Repayment of convertible note payable		(882,571)
Proceeds from issuance of common shares	43,088,006	1,343,750
Proceeds from exercise of share purchase warrants	318,750
Share issuance costs	(2,161,350)
Net Cash Provided by Financing Activities	41,245,406	1,536,179
Change in Cash	33,064,102	462,434
Cash – Beginning	12,843,502	829,924
Cash – End	45,907,604	1,292,358
Supplemental information:
Interest paid		30,662
Non-cash investing and financing activities:
Discount on convertible debenture		275,000
Original issuance discount on convertible debentures		43,500
Common shares issued for conversion of debt		1,770,232
Dividends declared	15,747
Common shares issued for conversion of Series C preferred shares	1,675,000
Fair value of commission warrants	$ 2,699,039